Finance

Lists
DEVA:IST
Deva Holding AS
TRY 85,85
-1,32%
(-1,15) 1D
9 ຕ.ລ., 18 ໂມງ 10 ນາທີ 00 ວິນາທີ GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for DEVA...
Open
TRY 87,35
High
TRY 88,30
Low
TRY 85,15
Mkt. cap
17,17 ຕື້
Avg. vol.
660,43 ພັນ
Volume
0,00
52-wk high
TRY 109,30
52-wk low
TRY 57,50
EPS
TRY-4,21
Shares outstanding
200,02 ລ້ານ
No. of employees
3 ພັນ
Open
TRY 87,35
High
TRY 88,30
Low
TRY 85,15
Mkt. cap
17,17 ຕື້
Avg. vol.
660,43 ພັນ
Volume
0,00
52-wk high
TRY 109,30
52-wk low
TRY 57,50
EPS
TRY-4,21
Shares outstanding
200,02 ລ້ານ
No. of employees
3 ພັນ
News stories
From web sources and news partners
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements. A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas. As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS
CEO-
Employees3,06 ພັນ
Founded22 ກ.ຍ. 1958
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TRY
Loading Previous Earnings...
Revenue
Net income
All values in TRY
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
4,47 ຕື້
5,49 ຕື້
6,33 ຕື້
6,00 ຕື້
Cost of goods sold
3,02 ຕື້
3,84 ຕື້
4,10 ຕື້
2,82 ຕື້
Cost of revenue
3,02 ຕື້
3,84 ຕື້
4,10 ຕື້
2,82 ຕື້
Research and development expenses
264,29 ລ້ານ
174,34 ລ້ານ
361,82 ລ້ານ
480,63 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,30 ຕື້
1,58 ຕື້
1,60 ຕື້
1,68 ຕື້
Operating expense
1,55 ຕື້
1,74 ຕື້
1,93 ຕື້
2,07 ຕື້
Total operating expenses
4,58 ຕື້
5,58 ຕື້
6,03 ຕື້
4,89 ຕື້
Operating income
-102,14 ລ້ານ
-89,10 ລ້ານ
293,59 ລ້ານ
1,11 ຕື້
Other non operating income
337,87 ລ້ານ
185,09 ລ້ານ
663,10 ລ້ານ
-172,42 ລ້ານ
EBT including unusual items
-137,34 ລ້ານ
-340,89 ລ້ານ
585,37 ລ້ານ
527,53 ລ້ານ
EBT excluding unusual items
-137,34 ລ້ານ
-362,51 ລ້ານ
586,40 ລ້ານ
527,53 ລ້ານ
Income tax expense
-116,52 ລ້ານ
1,00 ຕື້
682,64 ລ້ານ
-86,52 ລ້ານ
Effective tax rate
84,84%
-294,28%
116,62%
-16,40%
Other operating expenses
-9,80 ລ້ານ
-11,48 ລ້ານ
-34,86 ລ້ານ
-88,91 ລ້ານ
Net income
-20,81 ລ້ານ
-1,34 ຕື້
-97,27 ລ້ານ
614,05 ລ້ານ
Net profit margin
-0,47%
-24,48%
-1,54%
10,23%
Earnings per share
-
-
-
-
Interest and investment income
59,54 ລ້ານ
23,47 ລ້ານ
114,43 ລ້ານ
157,88 ລ້ານ
Interest expense
-617,63 ລ້ານ
-656,70 ລ້ານ
-542,37 ລ້ານ
-662,77 ລ້ານ
Net interest expenses
-558,09 ລ້ານ
-633,23 ລ້ານ
-427,95 ລ້ານ
-504,88 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
237,92 ລ້ານ
622,26 ລ້ານ
701,87 ລ້ານ
1,42 ຕື້
Gain or loss from assets sale
-15,06 ລ້ານ
-15,93 ລ້ານ
-32,28 ລ້ານ
-12,59 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google